MCM
TEVA icon

McKinley Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

McKinley Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,159,065
Closed -$17.9M – 293
2018
Q4 		$17.9M Sell
1,159,065
-385,610
-25% -$7.91M 1.45% 24
2018
Q3 		$33.3M Buy
+1,544,675
New +$35.9M 2.11% 12
2017
Q1 		– Sell
-24,315
Closed -$881K – 547
2016
Q4 		$881K Sell
24,315
-4,273
-15% -$171K 0.03% 256
2016
Q3 		$1.31M Sell
28,588
-834,263
-97% -$43.5M 0.05% 231
2016
Q2 		$43.3M Sell
862,851
-94,736
-10% -$5.04M 2.1% 3
2016
Q1 		$51.2M Sell
957,587
-9,795
-1% -$575K 2.47% 4
2015
Q4 		$63.5M Buy
967,382
+395,570
+69% +$24.4M 2.94% 3
2015
Q3 		$32.3M Buy
571,812
+253,884
+80% +$16.5M 1.57% 12
2015
Q2 		$18.8M Sell
317,928
-3,687
-1% -$227K 0.8% 36
2015
Q1 		$20M Buy
321,615
+292,048
+988% +$17M 0.8% 35
2014
Q4 		$1.7M Buy
29,567
+252
+0.9% +$14K 0.07% 201
2014
Q3 		$1.58M Buy
29,315
+26,794
+1,063% +$1.42M 0.07% 187
2014
Q2 		$132K Sell
2,521
-25,847
-91% -$1.32M 0.01% 316
2014
Q1 		$1.5M Buy
+28,368
New +$1.31M 0.06% 198

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

McKinley Capital Management's TEVA Position: Q1 2019 in Review

McKinley Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 1,159,065 shares — an estimated $17.9M sold.

McKinley Capital Management first reported a position in TEVA in Q1 2014 and held it in 14 quarters. The position peaked at $63.5M in Q4 2015. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • McKinley Capital Management reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • McKinley Capital Management sold 1,159,065 Teva Pharmaceuticals shares in Q1 2019, an estimated $17.9M.
  • McKinley Capital Management first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 14 quarters.
  • McKinley Capital Management's Teva Pharmaceuticals position peaked at $63.5M in Q4 2015.
  • 522 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on McKinley Capital Management's 13F filing for Q1 2019, filed 2 May 2019.